|NIH National Neurology Advisory Council Gains
Five New Members
The National Institute of Neurological Disorders and Stroke (NINDS)
welcomes five new members to its National Advisory Neurological
Disorders and Stroke Council. The Council serves as the principal
advisory body to the NINDS, a component of the National Institutes
of Health and the nation's primary supporter of basic, translational,
and clinical research on the brain and nervous system.
The Council meets three times each year to review applications
from scientists seeking financial support for biomedical research
and research training on disorders of the brain and nervous system.
Its members, who are appointed to four-year terms, also advise
the NINDS on research program planning and priorities. The 18-member
council is composed of physicians, scientists, and representatives
of the public.
NINDS Director Story Landis, Ph.D., introduced the new members
at the Council's September 20, 2007 meeting. The new members are:
Luis F. Parada, Ph.D.., is chair of the Department
of Developmental Biology at the University of Texas Southwestern
Medical Center in Dallas. He also directs the University's Kent
Waldrep Center for Basic Research on Nerve Growth and Regeneration.
Dr. Parada's research interests include charting regulatory pathways
involved in nervous system development, studying nerve cell signaling
disorders that lead to the development of tumors in the brain and
peripheral nervous system, and identifying molecules in myelin
that inhibit nerve cell regeneration following injury. He is currently
on the Scientific Advisory Board of the Pew Scholars Foundation
and is a past member of the Retts Syndrome Research Foundation
Board. His many honors include receiving the prestigious Javits
Neuroscience Investigator Award from the NIH. Dr. Parada is a member
of the American Academy of Arts and Sciences, the American Association
for the Advancement of Science (AAAS), and the Institute of Medicine.
Timothy A. Pedley, M.D., is the Henry and Lucy
Moses Professor of Neurology and chair of the Department of Neurology
at Columbia University College of Physicians and Surgeons. He is
also neurologist-in-chief at The New York-Presbyterian Hospital
and Columbia University Medical Center. His research interests
include clinical neurophysiology and electroencephalography, pathophysiology
of epilepsy, and family studies of epilepsy. Dr. Pedley is president
of the American Neurological Association, former president of the
American Epilepsy Society and the Epilepsy Foundation of America,
and past chair of the American Board of Clinical Physiology. He
is a member of the Institute of Medicine, the American Academy
of Neurology, the New York Academy of Medicine, and a Fellow of
the AAAS. He sits on the editorial boards of several scientific
and professional journals.
John T. Povlishock, Ph.D., is chair of the Department
of Anatomy and Neurobiology at Virginia Commonwealth University
(VCU) and director of the Commonwealth Center for the Study of
Brain Injury. He is also a professor of neurosurgery at VCU. His
research interests focus on traumatic brain injury in terms of
its neuronal and vascular consequences and their potential therapeutic
modifications. Dr. Povlishock's many honors include serving as
president of the Neurotrauma Society, several awards for teaching
excellence, and two Javits Neuroscience Investigator Awards. He
is editor-in-chief of the Journal of Neurotrauma.
Cindy Parseghian, M.B.A., is founder and president
of the Ara Parseghian Medical Research Foundation in Tucson, Ariz. — a
volunteer, nonprofit organization that funds research on the fatal
genetic disorder known as Niemann-Pick Disease Type C and related
neurodegenerative metabolic disorders. She has helped raise more
than $30 million dollars in research support and has directed the
research program that has expanded the number of labs researching
Niemann-Pick Type C from fewer than five to more than 55 worldwide
since the foundation's inception in 1994. Previously she was president,
chief financial officer, and controller of MCS Telecommunications
in Tucson, and has also worked as a certified public accountant.
Mrs. Parseghian earned her bachelorís degree from the University
of Notre Dame and her master's in business management from the
Northwestern University Kellogg School of Management.
Vicky Holets Whittemore, Ph.D., is vice president
and director of science at the Tuberous Sclerosis Alliance in Silver
Spring, Md. Dr. Whittemore has served as a member and chair of
the National Tuberous Sclerosis Association board of directors,
as well as vice president and medical director. She has also served
on the board of directors of the Genetic Alliance and is currently
vice-chair of the National Coalition for Health professional Education
in Genetics. She is a member of the CETT Review Panel for the Office
of Rare Disorders, NIH. She received her undergraduate degree in
zoology from Iowa State University and a doctorate in anatomy from
the University of Minnesota. Dr. Whittemore did a postdoctoral
fellowship at the University of California, Irvine, and a Fogarty
Fellowship at the Karolinska Institute in Stockholm, Sweden. She
was an associate professor at the Miami Project to Cure Paralysis,
the Department of Neurological Surgery, at the University of Miami,
Fla., before leaving to join the staff of the Tuberous Sclerosis
Alliance in 1994.
More information about the NINDS and its Advisory Council can
be found at the NINDS web site, www.ninds.nih.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.